We are live on ! Find out more
CSIC

Clifford Swan Investment Counsel Portfolio holdings

AUM $2.94B
1-Year Est. Return 21.31%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$1.25B
AUM Growth
+$56.5M
Cap. Flow
+$11.3M
Cap. Flow %
0.9%
Top 10 Hldgs %
27.25%
Holding
234
New
8
Increased
51
Reduced
100
Closed
5

Top Buys

Rank Stock Value
1
BEN icon
Franklin Resources
BEN
+$10.4M
2
EW icon
Edwards Lifesciences
EW
+$4.09M
3
AGN
Allergan Inc
AGN
+$1.99M
4
NVO
Novo Nordisk
NVO
+$1.95M
5
TPR icon
Tapestry
TPR
+$1.91M

Sector Composition

Rank Sector Weight
1 Industrials 17.9%
2 Technology 16.48%
3 Healthcare 14.41%
4 Energy 13.16%
5 Consumer Staples 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
$16.7M 1.33%
311,116
-19,207
-6% -$965K
JPM icon
27
JPMorgan Chase
JPM
$971B
$16.4M 1.31%
317,183
+867
+0.3% +$46.5K
PCP
28
DELISTED
PRECISION CASTPARTS CORP
PCP
$15.9M 1.27%
69,997
+1,652
+2% +$373K
BNY
29
Bank of New York Mellon
BNY
$111B
$15.3M 1.22%
506,601
-15,154
-3% -$465K
CSCO icon
30
Cisco
CSCO
$488B
$14.8M 1.18%
631,727
-21,666
-3% -$538K
PEP icon
31
PepsiCo
PEP
$189B
$14.5M 1.16%
182,886
-1,762
-1% -$145K
VCSH icon
32
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$14.3M 1.14%
180,092
+6,600
+4% +$524K
QCOM icon
33
Qualcomm
QCOM
$171B
$14.3M 1.14%
212,609
+27,603
+15% +$1.81M
PM icon
34
Philip Morris
PM
$290B
$14M 1.12%
162,251
-2,100
-1% -$184K
ABBV icon
35
AbbVie
ABBV
$440B
$13.8M 1.1%
307,622
-8,990
-3% -$399K
MMM icon
36
3M
MMM
$94.8B
$13.4M 1.07%
134,667
-6,339
-4% -$616K
A icon
37
Agilent Technologies
A
$41.9B
$12.8M 1.02%
350,235
-280
-0.1% -$9.44K
MCD icon
38
McDonald's
MCD
$195B
$11.9M 0.95%
123,202
-3,328
-3% -$325K
J icon
39
Jacobs Solutions
J
$17B
$11.1M 0.89%
231,008
-6,759
-3% -$329K
BEN icon
40
Franklin Resources
BEN
$17.1B
$10.8M 0.87%
+214,636
New +$10.4M
RTX icon
41
RTX Corp
RTX
$300B
$10.8M 0.86%
159,226
+19,149
+14% +$1.25M
TPR icon
42
Tapestry
TPR
$31.1B
$10.5M 0.84%
192,324
+34,774
+22% +$1.91M
SYY icon
43
Sysco
SYY
$40.5B
$10.5M 0.84%
329,270
-8,330
-2% -$279K
ABT icon
44
Abbott
ABT
$192B
$10.3M 0.82%
311,205
-2,619
-0.8% -$91.9K
WMT icon
45
Walmart Inc
WMT
$923B
$9.43M 0.75%
382,551
-14,808
-4% -$373K
RIG icon
46
Transocean
RIG
$6.37B
$8.92M 0.71%
200,502
+34,302
+21% +$1.62M
LH icon
47
Labcorp
LH
$26.2B
$8.54M 0.68%
100,293
+14,525
+17% +$1.22M
NVS icon
48
Novartis
NVS
$290B
$8.52M 0.68%
123,878
-1,134
-0.9% -$75K
BCR
49
DELISTED
CR Bard Inc.
BCR
$8.3M 0.66%
72,057
+1,195
+2% +$137K
BP icon
50
BP
BP
$111B
$8.26M 0.66%
240,248
-3,124
-1% -$107K

Similar funds

Clifford Swan Investment Counsel's Q3 2013 Portfolio in Review

As of Q3 2013, Clifford Swan Investment Counsel held 234 positions worth $1.25B, up 4.7% from $1.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Clifford Swan Investment Counsel's Q3 2013 filing shows 8 new, 51 increased, 100 reduced and 5 closed positions. Its largest new stake was Franklin Resources: 214,636 shares worth $10.8M. The largest sale was Lowe's Companies, an estimated $1.9M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Clifford Swan Investment Counsel's largest Q3 2013 buy was Franklin Resources: 214,636 shares worth $10.8M.
  • Clifford Swan Investment Counsel added most to Novo Nordisk in Q3 2013, an estimated $1.95M increase.
  • Clifford Swan Investment Counsel's biggest Q3 2013 reduction was Lowe's Companies, cutting an estimated $1.9M.
  • Clifford Swan Investment Counsel fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $653K.
  • Clifford Swan Investment Counsel's ten largest holdings make up 27% of its $1.25B portfolio in Q3 2013.
  • Clifford Swan Investment Counsel opened 8 new positions and closed 5 in Q3 2013.
  • Clifford Swan Investment Counsel's portfolio value rose 4.7% quarter-over-quarter to $1.25B.

Based on Clifford Swan Investment Counsel's 13F filing for Q3 2013, filed 24 Oct 2013.